← Back to all trials
Completed
NCT06545032
Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases
Conditions: Degenerative Spine Diseases
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 30
Sponsor: Sohag University
Location: Sohag University Sohag Sohag Governorate
Summary
The aim of this study is to evaluate clinical and surgical outcome of MI-TLIF for degenerative lumbar and lumbosacral spine diseases.
Eligibility Criteria
Inclusion Criteria:
* Degenerative spondylolisthesis.
* Degenerative unilateral disc herniations.
* Recurrent disc herniation.
Exclusion Criteria:
* Spondylolisthesis Grade III or IV.
* Degenerative scoliosis .
* Traumatic fracture spine.
* Infections.
* Neoplasms.
* Debilitated patients .
* Coagulation dysfunction.
* Severe osteoporosis.
Source: ClinicalTrials.gov (NCT06545032). StuddyBuddy aggregates publicly available trial information.
